Published in Infect Immun on February 01, 1998
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med (1969) 13.87
Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta (1957) 11.28
T cell-independent antigens type 2. Annu Rev Immunol (1995) 4.62
Meningococcal disease: still with us. Rev Infect Dis (1983) 4.36
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol (1981) 3.04
Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem (1981) 2.91
Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide. J Biol Chem (1971) 2.74
An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol (1987) 2.54
T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med (1981) 2.50
Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 2.42
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol (1977) 2.03
The immunological responses observed in field studies in Africa with group A meningococcal vaccines. Prog Immunobiol Stand (1971) 1.96
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J Immunol (1982) 1.54
Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Immunol (1990) 1.36
Intrasplenic primary immunization for the production of monoclonal antibodies. J Immunol Methods (1984) 1.33
Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous system. Neurosci Res (1993) 1.33
The analysis of lipopolysaccharide (endotoxin) in meningococcal polysaccharide vaccines by silver staining following SDS-polyacrylamide gel electrophoresis. J Biol Stand (1986) 1.29
Production and degradation of serogroup B Neisseria meningitidis polysaccharide. Infect Immun (1972) 1.27
Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid. Biochemistry (1995) 1.24
Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc Natl Acad Sci U S A (1991) 1.22
Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. Infect Immun (1985) 1.19
Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med (1996) 1.15
Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model. Infect Immun (1984) 1.11
Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Infect Dis (1991) 1.06
Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine. J Med Microbiol (1996) 1.06
The purification of mouse monoclonal antibodies from ascitic fluid. J Immunol Methods (1986) 1.06
Rate, mechanism, and immunochemical studies of lactonisation in serogroup B and C polysaccharides of Neisseria meningitidis. Carbohydr Res (1984) 1.03
T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J Infect Dis (1992) 1.02
Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide. Vaccine (1995) 1.00
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect Immun (1992) 1.00
T-cell modulation of the antibody response to bacterial polysaccharide antigens. Infect Immun (1989) 0.99
B cell memory to thymus-independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction. Eur J Immunol (1988) 0.97
Intramolecular self-cleavage of polysialic acid. J Biol Chem (1994) 0.97
Polysialic acid of the neural cell adhesion molecule (N-CAM) is widely expressed during organogenesis in mesodermal and endodermal derivatives. Differentiation (1994) 0.96
Further approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive bacterial disease. J Infect Dis (1992) 0.96
Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. I. Ontogeny. J Immunol (1988) 0.95
Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. J Immunol (1989) 0.95
Comparison of methods for the analysis of outer membrane antigens of Neisseria meningitidis by western blotting. J Immunol Methods (1990) 0.94
A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc Natl Acad Sci U S A (1992) 0.94
Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol (1995) 0.94
Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins. Vaccine (1991) 0.94
Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies. J Immunol (1987) 0.86
Improved fusion methods. IV. Technical aspects. J Immunol Methods (1985) 0.85
Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz J Med Biol Res (1995) 0.83
Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins. Infect Immun (1988) 0.81
The disialosyl group of glycoproteins. Occurrence in different tissues and cellular membranes. Eur J Biochem (1977) 0.80
Thymic-dependence and immune memory in mice vaccinated with meningococcal polysaccharide group B complexed to outer membrane protein. Immunology (1986) 0.79
Quantitation of antibody isotypes in solid-phase assays. Comparison of myeloma protein and monoisotypic antibody standards. J Immunol Methods (1985) 0.79
c-pathway polysialogangliosides in the nervous tissue of vertebrates, reacting with the monoclonal antibody Q211. Brain Res (1990) 0.76
Selective biotinylation of Neisseria meningitidis group B capsular polysaccharide and application in an improved ELISA for the detection of specific antibodies. J Immunol Methods (1993) 0.88
Role of immunoglobulin G subclasses in Q fever. Eur J Clin Microbiol Infect Dis (1995) 0.79
Autoantibody profiles in the sera of patients with Q fever: characterization of antigens by immunofluorescence, immunoblot and sequence analysis. J Autoimmune Dis (2005) 0.78
The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection. Microb Pathog (1999) 0.78
Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. J Drug Target (2003) 0.78
Distribution of IgA subclass response to Coxiella burnetii in patients with acute and chronic Q fever. Clin Immunol Immunopathol (1998) 0.76
Distribution of immunoglobulin G (IgG) and A (IgA) subclasses following Q fever vaccination with soluble phase I Coxiella burnetii extract. Vaccine (2000) 0.75
Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development. J Infect Dis (2001) 0.75